Published Date:2022-08-23 Original Link:https://www.onenessbio.com/en/news_detail175_2.htm No 1 Date of announcement 2022/08/23 Time of announcement 22:58:56 Subject Oneness submitted an IND to US FDA for a phase I clinical trial on the broad-spectrum anti-SARS-CoV-2 siRNA (SNS812) co-developed with Microbio (Shanghai) To which item it meets paragraph 10 Date of events 2022/08/23 Statement Product:SNS812, a broad-spectrum siRNA against...Read More
Published Date:2022-08-20 Original Link:https://www.onenessbio.com/en/news_detail174_2.htm No 2 Date of announcement 2022/08/20 Time of announcement 19:13:32 Subject US FDA notified today that 510(k) Premarket Notification of Bonvadis, the wound care topical cream was substantially equivalent. To which item it meets paragraph 10 Date of events 2022/08/20 Statement Product:Bonvadis topical cream for wound care Mass production date:NA Effect...Read More
Published Date:2022-08-11 Original Link:https://www.onenessbio.com/en/news_detail173_2.htm No 1 Date of announcement 2022/08/11 Time of announcement 17:47:48 Subject The Company’s 2022Q2 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 10 Date of events 2022/07/04 Statement Date of the board of directors submitted or approved:2022/08/11 Date of the audit committee...Read More
Published Date:2022-07-04 Original Link:https://www.onenessbio.com/en/news_detail172_2.htm No 1 Date of announcement 2022/07/04 Time of announcement 19:48:10 Subject The Drug Administration of Vietnam has accepted the NDA application of the diabetic foot ulcer new drug, Fespixon To which item it meets paragraph 10 Date of events 2022/07/04 Statement Product: ON101, diabetic foot ulcer new drug Mass production date:...Read More
Date 2022/06/29 Location Online Presentation Download Download Chinese Version Download English Version Video Recording (English interpretation) Note N/ARead More
Published Date:2022-06-22 Original Link:https://www.onenessbio.com/en/news_detail170_2.htm No 1 Date of announcement 2022/06/22 Time of announcement 17:25:53 Subject Oneness announces the information about the investor’s conference of 2022 Q2. To which item it meets paragraph 12 Date of events 2022/06/29 Statement Date of institutional investor conference:2022/06/29 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More
Published Date:2022-06-02 Original Link:https://www.onenessbio.com/en/news_detail169_2.htm No 1 Date of announcement 2022/06/02 Time of announcement 20:24:50 Subject The findings of the MoA studies on Fespixon(ON101) under collaboration with TMU and NYCU have been accepted and published by a renown SCI journal, JID Innovations To which item it meets paragraph 53 Date of events 2022/06/02 Statement Date of...Read More
Published Date:2022-05-26 Original Link:https://www.onenessbio.com/en/news_detail168_2.htm No 1 Date of announcement 2022/05/26 Time of announcement 16:41:48 Subject Oneness Biotech Co.,LTD receives a China patent on antagonistic PDL1 aptamers. To which item it meets paragraph 53 Date of events 2022/05/26 Statement Date of occurrence of the event:2022/05/26 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter...Read More
Published Date:2022-05-24 Original Link:https://www.onenessbio.com/en/news_detail167_2.htm No 3 Date of announcement 2022/05/24 Time of announcement 19:17:23 Subject The Annual General Shareholders’ Meeting approved the removal of non-competition restriction on the newly-elected director. To which item it meets paragraph 21 Date of events 2022/05/24 Statement Date of the shareholders’ meeting resolution:2022/05/24 Name and title of the managerial officer...Read More
